Article
Source: www.biotechnologyhealthcare.com Austin, Texas ? Introgen Therapies announced initiation of a Phase II clinical trial of INGN 241 in patients with metastatic melanoma.
The Future of Pediatric Care at MOPD
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Pediatric Patients with Atopic Dermatitis Have Lower SCH and Higher TEWL, Compared to Those Without
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
Pediatric Melanoma in Review: Providing Considerations for Dermatologists
Shanna Miranti, MPAS, PA-C, Shares Expert Acne and Pediatric Dermatology Insights